je.st
news
Tag: candidate
K&N Vice President Tim Martin is Candidate in 2013 SEMA Chairman of the Board Election
2013-04-30 05:36:57| K&N Engineering, Inc. Corporate News
Every two years, SEMA selects a new volunteer Chairman of the SEMA Board of Directors. Tim Martin of K&N Engineering has been chosen as one of two finalists for the 2013 SEMA Chairman election.
Tags: the
board
martin
president
Second Superintendent Candidate Drops Out
2013-04-16 21:03:26| Industrial Machines - Topix.net
Yet another candidate to become the Easton Area School District's new superintendent has decided he doesn't want the job.
Tags: candidate
drops
superintendent
Tanzania Emerges As Candidate for Green Gas Emissions
2013-04-09 11:31:00| Climate Ark Climate Change & Global Warming Newsfeed
East African Business Week: Tanzania could join the list of leading African nations in greenhouse gas emissions in the future. This is if its ambitious plans to utilize coal and natural gas for power generation will not take environmental conservation into account, an expert has warned. Presenting a paper on "the global context and debates surrounding energy and environment", the Director of Tanzania Specialist Organization on Community Natural Resources and Biodiversity Conservation (TASONABI), Mr. Bariki Kaale explained...
Tags: green
gas
candidate
tanzania
Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
2013-03-28 09:57:29| dairynetwork Home Page
Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.
Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
2013-03-28 09:57:29| dairynetwork News Articles
Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.
Sites : [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] next »